Ask The Board

  1. What Advice Do You Have For Preventing Fraud Schemes In Large Phase 3 Studies?
    11/1/2019

    See the answer from Dr. Axel Hoos, SVP, R&D governance chair, and therapeutic area (TA) head for oncology at GSK.

  2. What Advice Do You Have For Executives Considering Ex-Pat Opportunities In South American Countries?
    11/1/2019

    See the answer from Raúl Diaz, who directs MSD Animal Health Large Molecules Biopharm Operations in Montes Claros, Brazil.

  3. What Advice Do You Have For An Executive Weighing An Exit From A Company For Which They Are A Leader And A Board Member?
    11/1/2019

    See the answer from Rich Daly, COO of BeyondSpring, who has more than 25 years of biopharmaceutical industry leadership experience.

  4. What Is The Most Ridiculous Justification You Have Ever Heard To Rationalize An Inefficient /Expensive Capital Structure?
    10/1/2019

    See the answer from Allan Shaw, a four-time public company CFO who has served on five public boards.

  5. What Advice Do You Have For Women Interested In Becoming Senior-Level Leaders And Serving On Corporate Boards Of Biopharma Companies?
    10/1/2019

    See the answer from Laurie Cooke, BS, RPh, PGDip, CAE, who is the CEO of HBA, a global nonprofit professional association.

  6. What Was The Most Valuable Experience/Training That Prepared You For The Role Of CFO?
    10/1/2019

    See the answer from Joseph Ferra, CFO of Syros Pharmaceuticals.

  7. What Should Be Done By Engineers Toward Developing New Methods And Approaches For Process Development And Facility Design To Make The Wide Range Of New Products Faster And Cheaper?
    8/30/2019

    See the answer from Charlene Banard, former head of quality, technical operations at Shire.

  8. What Are The Critical Components Necessary When Attempting To Attract An Angel Investor To Your Biopharma Startup?
    8/30/2019

    See the answer from Martin Lehr, CEO and cofounder at Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing novel medicines for hormone receptor positive cancers.

  9. What Are The Critical Components Necessary When Attempting To Attract An Angel Investor To Your Biopharmaceutical Startup?
    8/30/2019

    See the answer from Dennis Purcell, a founder and senior advisor of Aisling Capital, who has completed over 200 transactions and supervised over $15 billion life science industry financing and advisory assignments.

  10. How Do You View The Integration Of Clinical Research With Clinical Care, And What Approaches Align To Make Clinical Trials Potential Care Options?
    8/1/2019

    See the answer from Kenneth Moch, president and CEO of Cognition Therapeutics.